Literature DB >> 8510931

New human erg isoforms generated by alternative splicing are transcriptional activators.

M Duterque-Coquillaud1, C Niel, S Plaza, D Stehelin.   

Abstract

The erg gene is a member of the ets gene family. ETS proteins have been shown to bind specifically the (GGA-A/T) motif and to transactivate via this consensus sequence. The human erg products exhibit approximately 70% homology with ETS proteins in their DNA-binding domain. We have isolated three erg cDNAs from a human fetal liver library. Two of them are different from the previously described erg-1 and erg-2 cDNAs (Rao et al., Science, 1987, 237, 635-639), in the middle of their coding sequence and in their 5' part where a novel initiation codon is introduced. These isoforms are generated by alternative RNA splicing from a single gene that leads to the inclusion or exclusion of different exon sequences. The three cDNAs expressed by an in vitro transcription-translation system direct the synthesis of proteins of approximately 38, 49 and 55 kDa. These in vitro erg products were tested for their DNA-binding activity by gel mobility-shift assays with different probes containing the ETS-specific binding site. The results indicated that all these erg isoforms are able to bind the ETS binding site in a specific manner. Our data using transient transfection assays indicate that erg protein isoforms function as transcriptional activators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510931

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).

Authors:  H Ichikawa; K Shimizu; R Katsu; M Ohki
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites.

Authors:  P J Valk; M Joosten; Y Vankan; B Löwenberg; R Delwel
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

Review 3.  Cellular and molecular mechanisms of synovial joint and articular cartilage formation.

Authors:  Maurizio Pacifici; Eiki Koyama; Yoshihiro Shibukawa; Changshan Wu; Yoshihiro Tamamura; Motomi Enomoto-Iwamoto; Masahiro Iwamoto
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

4.  EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.

Authors:  M Giovannini; J A Biegel; M Serra; J Y Wang; Y H Wei; L Nycum; B S Emanuel; G A Evans
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 5.  ERG expression in prostate cancer: biological relevance and clinical implication.

Authors:  Hatem Abou-Ouf; Liena Zhao; Tarek A Bismar
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-28       Impact factor: 4.553

6.  Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis.

Authors:  Masahiro Iwamoto; Yoshihiro Tamamura; Eiki Koyama; Toshihisa Komori; Nobuo Takeshita; Julie A Williams; Takashi Nakamura; Motomi Enomoto-Iwamoto; Maurizio Pacifici
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

Review 7.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.

Authors:  N Soudant; O Albagli; P Dhordain; A Flourens; D Stéhelin; D Leprince
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

Review 9.  ETS gene fusions in prostate cancer.

Authors:  Jeremy P Clark; Colin S Cooper
Journal:  Nat Rev Urol       Date:  2009-08       Impact factor: 14.432

10.  Pax-QNR/Pax-6, a paired- and homeobox-containing protein, recognizes Ets binding sites and can alter the transactivating properties of Ets transcription factors.

Authors:  S Plaza; D Grevin; K MacLeod; D Stehelin; S Saule
Journal:  Gene Expr       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.